Payment overview · 2025
General Payments
$82.06
4 reported records · 2 companies
Healthcare provider profile · identity verified
Andy A Roberts, M.D.
Allopathic & Osteopathic Physicians|Family Medicine · GREENEVILLE, TN · NPI 1013900943
Verified facts
What the public records show
CMS Open Payments records show Andy A Roberts, M.D. received $82.06 in general payments during 2025 across 4 reported records.
Novo Nordisk Inc accounted for 82.9% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 3 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Rybelsus.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Rybelsus as an associated drug or biological on 161257 records involving 55409 distinct recipient NPIs. Public Medicare Part D data also shows 22 claims for Rybelsus by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Novo Nordisk Inc | Unresolved — no canonical attribution shown | $68.02 | 82.9% | 3 | 2025 |
| Exact Sciences Corporation | Unresolved — no canonical attribution shown | $14.04 | 17.1% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $82.06 | 4 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Ozempic Normalized: ozempic |
Drug | Novo Nordisk Inc | $68.02 | 3 | 2025 |
Source payment records
|
|||||
| Rybelsus Normalized: rybelsus |
Drug | Novo Nordisk Inc | $45.27 | 2 | 2025 |
Source payment records
|
|||||
| The Cologuard Plus Collection Kit Normalized: the cologuard plus collection kit |
Device | Exact Sciences Corporation | $14.04 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| Rybelsus rybelsus |
2025 | Rybelsus | 2024 | 22 Beneficiary count suppressed |
exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Rybelsus open payments reported associated product |
CMS Open Payments — General Payments 161257 supporting records · 55409 recipient NPIs · example record 1188130076 |
Rybelsus · 2024 Exact normalized brand match · 1 Part D row |
22 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Alprazolam | Alprazolam | 752 | 93 |
| Levothyroxine Sodium | Levothyroxine Sodium | 717 | 176 |
| Lisinopril | Lisinopril | 494 | 128 |
| Amlodipine Besylate | Amlodipine Besylate | 472 | 119 |
| Omeprazole | Omeprazole | 415 | 104 |
| Atorvastatin Calcium | Atorvastatin Calcium | 385 | 102 |
| Lorazepam | Lorazepam | 380 | 50 |
| Pantoprazole Sodium | Pantoprazole Sodium | 350 | 91 |
| Metformin Hcl | Metformin Hcl | 332 | 87 |
| Hydrochlorothiazide | Hydrochlorothiazide | 309 | 82 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 303 | 81 |
| Gabapentin | Gabapentin | 288 | 72 |
| Tramadol Hcl | Tramadol Hcl | 269 | 30 |
| Glimepiride | Glimepiride | 263 | 70 |
| Losartan Potassium | Losartan Potassium | 263 | 68 |
| Prednisone | Prednisone | 252 | 124 |
| Furosemide | Furosemide | 248 | 95 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 235 | 46 |
| Pravastatin Sodium | Pravastatin Sodium | 231 | 57 |
| Zolpidem Tartrate | Zolpidem Tartrate | 229 | 32 |
| Doxycycline Hyclate | Doxycycline Hyclate | 227 | 139 |
| Potassium Chloride | Potassium Chloride | 212 | 55 |
| Metoprolol Tartrate | Metoprolol Tartrate | 201 | 49 |
| Benazepril Hcl | Benazepril Hcl | 168 | 42 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 167 | 42 |
| Simvastatin | Simvastatin | 167 | 44 |
| Meloxicam | Meloxicam | 165 | 51 |
| Montelukast Sodium | Montelukast Sodium | 146 | 43 |
| Eliquis | Apixaban | 136 | 32 |
| Tamsulosin Hcl | Tamsulosin Hcl | 136 | 41 |
| Famotidine | Famotidine | 133 | 36 |
| Azithromycin | Azithromycin | 131 | 90 |
| Metoprolol Succinate | Metoprolol Succinate | 125 | 32 |
| Clopidogrel | Clopidogrel Bisulfate | 122 | 35 |
| Allopurinol | Allopurinol | 120 | 31 |
| Citalopram Hbr | Citalopram Hydrobromide | 119 | 28 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 114 | 40 |
| Atenolol | Atenolol | 106 | 24 |
| Sertraline Hcl | Sertraline Hcl | 97 | 29 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 95 | 19 |
| Metformin Hcl Er | Metformin Hcl | 93 | 28 |
| Pioglitazone Hcl | Pioglitazone Hcl | 91 | 25 |
| Ezetimibe | Ezetimibe | 89 | 25 |
| Spironolactone | Spironolactone | 82 | 23 |
| Carvedilol | Carvedilol | 81 | 22 |
| Clonazepam | Clonazepam | 81 | 11 |
| Trazodone Hcl | Trazodone Hcl | 75 | 19 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 74 | 57 |
| Warfarin Sodium | Warfarin Sodium | 74 | 22 |
| Diclofenac Sodium | Diclofenac Sodium | 73 | 21 |
| Fluticasone Propionate | Fluticasone Propionate | 73 | 31 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 73 | 20 |
| Chlorthalidone | Chlorthalidone | 71 | 17 |
| Glipizide | Glipizide | 69 | 20 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 69 | 31 |
| Mounjaro | Tirzepatide | 67 | 13 |
| Dicyclomine Hcl | Dicyclomine Hcl | 66 | 22 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 66 | 19 |
| Celecoxib | Celecoxib | 65 | 21 |
| Duloxetine Hcl | Duloxetine Hcl | 64 | 18 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 63 | 16 |
| Methocarbamol | Methocarbamol | 62 | 31 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 61 | 16 |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 60 | 16 |
| Amoxicillin | Amoxicillin | 58 | 48 |
| Hydralazine Hcl | Hydralazine Hcl | 57 | 15 |
| Meclizine Hcl | Meclizine Hcl | 57 | 26 |
| Estradiol | Estradiol | 56 | 16 |
| Tizanidine Hcl | Tizanidine Hcl | 56 | 13 |
| Alendronate Sodium | Alendronate Sodium | 55 | 17 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 55 | 41 |
| Xarelto | Rivaroxaban | 55 | 12 |
| Ondansetron Hcl | Ondansetron Hcl | 54 | 27 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 54 | 12 |
| Lovastatin | Lovastatin | 53 | 17 |
| Ropinirole Hcl | Ropinirole Hcl | 52 | 12 |
| Mirtazapine | Mirtazapine | 51 | 12 |
| Baclofen | Baclofen | 50 | 18 |
| Clonidine Hcl | Clonidine Hcl | 50 | 14 |
| Levofloxacin | Levofloxacin | 50 | 34 |
| Diazepam | Diazepam | 48 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 47 | 12 |
| Enalapril Maleate | Enalapril Maleate | 47 | 13 |
| Fluoxetine Hcl | Fluoxetine Hcl | 47 | 12 |
| Escitalopram Oxalate | Escitalopram Oxalate | 46 | 12 |
| Oxycodone Hcl | Oxycodone Hcl | 44 | 11 |
| Donepezil Hcl | Donepezil Hcl | 43 | 13 |
| Dropsafe Prep Pads | Alcohol Antiseptic Pads | 43 | 12 |
| Terazosin Hcl | Terazosin Hcl | 43 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 42 | 32 |
| Promethazine Hcl | Promethazine Hcl | 42 | 12 |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 41 | 14 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 41 | 11 |
| Ipratropium Bromide | Ipratropium Bromide | 39 | 24 |
| Jardiance | Empagliflozin | 39 | 15 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 39 | suppressed |
| Fluconazole | Fluconazole | 37 | 25 |
| Carisoprodol | Carisoprodol | 36 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 35 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 35 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 35 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 34 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 34 | suppressed |
| Cephalexin | Cephalexin | 33 | 30 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 33 | suppressed |
| Pregabalin | Pregabalin | 33 | 16 |
| Nifedipine Er | Nifedipine | 32 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 31 | suppressed |
| Bumetanide | Bumetanide | 29 | suppressed |
| Nitroglycerin | Nitroglycerin | 29 | suppressed |
| Trulicity | Dulaglutide | 29 | suppressed |
| Cefdinir | Cefdinir | 28 | 18 |
| Lansoprazole | Lansoprazole | 28 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 28 | suppressed |
| Temazepam | Temazepam | 28 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 27 | 17 |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 26 | suppressed |
| Finasteride | Finasteride | 26 | suppressed |
| Gemfibrozil | Gemfibrozil | 26 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 26 | 25 |
| Nabumetone | Nabumetone | 25 | suppressed |
| Naproxen | Naproxen | 25 | 15 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 25 | suppressed |
| Ranolazine Er | Ranolazine | 24 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 23 | 13 |
| Levetiracetam | Levetiracetam | 23 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 23 | suppressed |
| Primidone | Primidone | 23 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 22 | suppressed |
| Benazepril-Hydrochlorothiazide | Benazepril/Hydrochlorothiazide | 22 | suppressed |
| Fenofibrate | Fenofibrate | 22 | suppressed |
| Metolazone | Metolazone | 22 | suppressed |
| Rybelsus | Semaglutide | 22 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 22 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 22 | suppressed |
| Verapamil Er | Verapamil Hcl | 22 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 21 | suppressed |
| Glipizide-Metformin | Glipizide/Metformin Hcl | 20 | suppressed |
| Linzess | Linaclotide | 20 | suppressed |
| Tresiba Flextouch U-200 | Insulin Degludec | 20 | suppressed |
| Irbesartan | Irbesartan | 19 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 19 | suppressed |
| Phenobarbital | Phenobarbital | 19 | suppressed |
| Valsartan | Valsartan | 19 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 18 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 18 | suppressed |
| Fosinopril Sodium | Fosinopril Sodium | 18 | suppressed |
| Febuxostat | Febuxostat | 17 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 17 | suppressed |
| Ibuprofen | Ibuprofen | 17 | 11 |
| Toujeo Max Solostar | Insulin Glargine,hum.Rec.Anlog | 17 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 16 | suppressed |
| Nystatin | Nystatin | 16 | 12 |
| Spironolactone-Hctz | Spironolact/Hydrochlorothiazid | 16 | suppressed |
| Acyclovir | Acyclovir | 15 | suppressed |
| Colchicine | Colchicine | 15 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 15 | suppressed |
| Sucralfate | Sucralfate | 15 | suppressed |
| Synthroid | Levothyroxine Sodium | 15 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 14 | suppressed |
| Memantine Hcl | Memantine Hcl | 14 | suppressed |
| Mupirocin | Mupirocin | 14 | suppressed |
| Novolog Flexpen | Insulin Aspart | 14 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 13 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 13 | suppressed |
| Hydrocortisone | Hydrocortisone | 13 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 13 | suppressed |
| Ibu | Ibuprofen | 13 | suppressed |
| Novolin 70-30 | Insulin Nph Hum/Reg Insulin Hm | 13 | suppressed |
| Betamethasone Dipropionate | Betamethasone Dipropionate | 12 | suppressed |
| Clorazepate Dipotassium | Clorazepate Dipotassium | 12 | suppressed |
| Emgality Pen | Galcanezumab-Gnlm | 12 | suppressed |
| Januvia | Sitagliptin Phosphate | 12 | suppressed |
| Niacin Er | Niacin | 12 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 12 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 12 | suppressed |
| Ondansetron Odt | Ondansetron | 12 | suppressed |
| Sulfasalazine | Sulfasalazine | 12 | suppressed |
| Dilt-Xr | Diltiazem Hcl | 11 | suppressed |
| Droplet Pen Needle | Pen Needle, Diabetic | 11 | suppressed |
| Felodipine Er | Felodipine | 11 | suppressed |
| Glipizide Er | Glipizide | 11 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 11 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $82.06 · 4 records | Novo Nordisk Inc | Ozempic, Rybelsus, The Cologuard Plus Collection Kit | 1 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Rybelsus play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with Novo Nordisk Inc?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error